News - Miraculins Inc.
2008-09-23 15:00:34
Miraculins Inc. (TSX VENTURE: MOM), a medical diagnostic company focused on developing and commercializing diagnostic tests for unmet clinical needs, announces that the Board of Directors has granted 500,000 options at an exercise price of $0.15 per share to Mr.